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Recanalization of arterial thrombus, and inhibition
with -radiation in a new murine carotid occlusion
model: mRNA expression of angiopoietins,
metalloproteinases, and their inhibitors
Jean Raymond, MD,a Vickie Lebel, MSc,a Christelle Ogoudikpe, MSc,a Annick Metcalfe, MSc,a Miguel
Chagnon, MSc,b and Olivier Robledo, PhD,a Montreal, Quebec, Canada
Background:Recanalization is an important physiologic phenomenon because it can efficiently reestablish circulation after
thrombosis. We attempted to characterize molecular events related to recanalization or organization of arterial thrombus
in a new murine model by studying genes reported to be involved in angiogenesis or neointima formation.
Methods: Platinum coils, radioactive phosphorus 32 coils or not, were implanted in the carotid artery in mice to cause
thrombotic occlusion. The outcome of the occlusion was followed up with transmyocardial angiography and pathologic
analysis at 2, 6, or 15 days. Angiographic results were compared with the Pearson 2 test. Messenger RNA expression of
vonWillebrand factor (vWF); smoothmuscle-actin (SMA); platelet endothelial cell adhesionmolecule-1 (PECAM-1);
vascular endothelium cadherin (VE-Cad); endothelial nitric oxide synthase (eNOS); vascular cell adhesion molecule-1
(VCAM-1); tumor necrosis factor alpha (TNF-); matrix metalloproteinase (MMP-9, MMP-12, and MMP-14), and
tissue inhibitors of MMPs (TIMPs: TIMP-1, TIMP-2, TIMP-3, TIMP-4); angiopoietins (Ang-1, Ang-2); and receptors
Tie-1 and Tie-2, were analyzed with reverse transcriptase polymerase chain reaction 2, 6, and 15 days after surgery. Levels
of mRNA expression were compared with analysis of variance and the Student t test.
Results: Carotid arteries implanted with nonradioactive 0.015-caliber coils were occluded in 84% of arteries on day 2, but in
only 57% of arteries on day 15, which confirms that recanalization occurred in this model. Arteries implanted with
0.015-caliber 32P coils did not become recanalized, and 100%were occluded on day 15 (n 13;P .006). Recanalizationwas
associated with endothelial-like cell-lined channels, whereas persistent occlusion was caused by complete filling of the lumen
with conjunctive tissue. Coil occlusion, with or without recanalization, was followed by decreased expression of vWf, VE-Cad,
eNOS, VCAM-1, MMP-2, TIMP-1, and TIMP-2; stable expression of PECAM-1, SMA, and TIMP-3; and overexpression
of Ang-1 and Ang-2, MMP-9, MMP-14, and TIMP-4. Statistically significant differences when arteries were implanted with
32P coils included decreased expression of TIMP-4 (P  .011) and increased expression of MMP-9 (P  .02).
Conclusion: Recanalization and organization of arterial thrombus is associated with expression of genes involved in
angiogenesis and neointima formation. Recanalization can be prevented with -radiation, but molecular mechanisms
remain to be refined. (J Vasc Surg 2004;40:1190-8.)
Clinical Relevance: A better understanding of molecular mechanisms involved in angiogenesis has permitted its
regulation as a new option in treatment of various diseases. Inhibition of angiogenesis may help control diseases such as
cancer, arthritis, or diabetes retinopathy. On the other hand, stimulation of angiogenesis may palliate conditions
associated with insufficient blood supply, such as ischemic heart disease or critical limb ischemia. Yet little is known
regarding recanalization (to be differentiated from thrombolysis), a cellular process that occurs concurrently with
thrombus “organization.” Recanalization is an important physiologic phenomenon because it can efficiently reestablish
antegrade circulation after thrombosis both in veins and in arteries, and could be modulated for therapeutic purposes.
Thus our efforts at better understanding of mechanisms involved in recanalization could be used, in addition to its
promotion to recover flow after thrombotic occlusions, to prevent its occurrence after endovascular interventions
designed to permanently occlude aneurysms.Murine vascular models have permitted considerable
progress in understanding of mechanisms involved in arte-
rial thrombosis, neointima formation, and development of
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1190collateral circulation by angiogenetic and more recently
vasculogenetic pathways.1-4 Yet little is known regarding
recanalization, a cellular process that occurs with thrombus
“organization”5-7 and described by pathologists for de-
cades.8 Recanalization is an important physiologic phe-
nomenon because it can efficiently reestablish antegrade
circulation after thrombosis both in veins and in arteries,
and thus it could be modulated for therapeutic purposes.
Recanalization is routinely found after platinum coil
occlusion of canine arteries, and could be involved in
recurrences after endovascular treatment of human intra-
cranial aneurysms.9-12 Deficient recanalization has not
been described, except perhaps in transgenic mice,13 but
it is conceivable that it could be impaired in diseases
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such as diabetes.14
A better understanding of molecular events related to
recanalization could lead to interventions designed to pro-
mote or prevent its occurrence. If inhibition of recanaliza-
tion could improve results of neurovascular interventions,
its promotion may find a role in the subacute management
of occlusive vascular disorders such as lower limb ischemia.
We have previously described canine models that were
helpful in assessing neurovascular devices currently used in
clinical practice, but they are limited in terms of biomolec-
ular tools essential to exploration of mechanisms of recan-
alization.9-12 Development of a new murine arterial coil
occlusion model is presented. This model was designed to
enable future in-depth studies of recanalization mecha-
nisms and to assess the competence of this phenomenon in
models of atherosclerosis or diabetes, in transgenic animals
or cell grafting experiments.1,7,13
Recanalization, but not thrombus organization, can
reliably be prevented in canine arteries by in situ -radiation
at low doses.9-12 By using radioactive or nonradioactive
coils in this murine model, we confirmed inhibition of
recanalization with -radiation and attempted to identify
molecular events related to thrombus organization, with or
without recanalization. Many mechanistic avenues could
have been explored, but because organization and recana-
lization of thrombus may share conceptual mechanisms
with neointima formation and angiogenesis, respectively,
we chose to address first messenger RNA expression of
some endothelial and neointimal cell markers, and growth
factors and metalloproteinases reportedly involved in these
phenomena (Table).
MATERIAL AND METHODS
Experimental animals and surgical procedure. Two
hundred thirteen C57BL/6 wild-type mice (Charles River)
weighing 18 to 20 g were administered preoperative and
postoperative analgesia with 0.03 mg/kg of buprenorphine
hydrochloride before and for 2 days after surgery. All
experimental procedures were approved by the institutional
animal care committee in accordance with guidelines of the
Canadian Council on Animal Care. Animals were anesthe-
tized with isoflurane. A midline cervical incision was made
to access the right carotid artery, which was carefully dis-
sected. A drop of bupivacaine (0.25%) was locally applied.
The right carotid artery was exposed and elevated with 2
6-0 polypropylene sutures. A 25-gauge needle bent at 90
degrees was used to perform the arteriotomy, and a
stretched platinum coil of 0.010 or 0.015 caliber, 2.7 0.6
mm long (Target Therapeutics, Boston Scientific), radio-
active or not radioactive, was introduced into the right
carotid artery (Fig 1). Because 0.015-caliber coils led to
more reliable initial occlusions (see Results), all further
experiments and reverse transcriptase–polymerase chain re-
action (RT-PCR) analyses were performed with these coils.
The sutures were removed and the arteriotomy site con-
trolled with local compression. The incision was closed
with 6-0 polypropylene sutures.Ion implantation of coils. Phosphorus 32 coils were
produced as previously described10 on a dedicated radioac-
tive ion implanter at Université de Montréal. 32P was
purchased from Perkin-Elmer Life Sciences. Coils, a kind
gift from Target Therapeutics, were measured after implan-
tation, identified, sterilized, and inserted into Plexiglas
boxes. Coils were sectioned every 2 to 3 mm, and for each
segment to be implanted into the carotid artery the 32P
activity in adjacent segments was counted, as described.10
Mean coil linear activity was 0.023 0.018 Ci/mm, and
mean volumetric activity inserted into carotid arteries was
0.23  0.16 Ci/mm3.
Transmyocardial angiography and sacrifice. Angi-
ography was performed at 2, 6, or 15 days after surgery.
Mice were injected with a lethal dose of pentobarbital
(Somnotol; MTC Pharmaceuticals, Cambridge, Ontario,
Canada) (65 mg/mL; 120 mg/kg intraperitoneally) just
before angiography. A 1-mL syringe filled with radiopaque
contrast medium (iodixanol [Visipaque], 320 mg/mL)
and a 22-gauge needle were used. The chest was opened
and the needle inserted in the left ventricle for injection. A
left lateral oblique projection was used in all animals, and
digital subtraction images were interpreted with blinded
assessment (Fig 1). Occlusion was defined as the absence of
anterograde blood flow through the coiled arterial seg-
ment; any antegrade opacification was sufficient to label the
artery as recanalized.
Pathologic technique. In brief, right and left carotid
arteries in each mouse were carefully dissected, fixed in 10%
neutral buffered formalin, and embedded in paraffin. In
certain specimens the coils were carefully removed under an
operating microscope after 24 hours of fixation. Alterna-
tively, the carotid arteries were left in situ, and the head and
neck were fixed en bloc before embedding and axial sec-
tioning. Specimens, including the coil, were cut with an
Exakt diamond saw after dehydratation and embedding in
Technovit 7200 resin (Heraeaus Kulzer). Slides were
stained with hematoxylin-eosin, Verhoeff–van Gieson, or
hematoxylin-phloxine-saffron, as described.9
RNA isolation and RT-PCR analysis. Isolation of
total cellular RNA was performed with the Micro-to-Midi
system (Invitrogen) according to the manufacturer’s in-
structions. Aliquots of total cellular RNA (500 ng) were
used for first-strand complementary DNA synthesis in 20
L of reaction volume with Superscript II reverse transcrip-
tase (Invitrogen). After determining the linear range of
RT-PCR for each of the target genes, amplification of the
gene under investigation was carried out with primers
(Table) and chosen in 2 different exons to distinguish
genomic contamination. PCR amplifications were per-
formed with platinium Taq DNA polymerase (Invitrogen)
according to the manufacturer’s instructions, on an Epen-
dorf Mastercycler gradient, with the following program:
step 1, 94°C for 1 minute; step 2, 52°C to 64°C for 1
minute; and step 3, 72°C for 1 minute (Table). Forty cycles
were performed for amplification of genes of interest, and
30 cycles for -actin. The amplification for each gene was in
the linear curve. PCR products were visualized on 1.5% aga-
thase;
ode; T
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sillumination. Quantitative analysis was carried out with a
computerized densitometric imager (ImageQuant) to obtain
genes to -actin ratios. For each gene, results from 7 to 24
specimens per time point were used for analysis.
Statistical analysis. Angiographic occlusion rates at
different times with radioactive or nonradioactive coils of
various caliber were compared with the Pearson 2 test.
mRNA expression levels, analyzed with densitometry, were
compared with the Student t test and analysis of variance,
followed, if necessary, with the Tukey test. To control the
false discovery rate, the Benjamini and Hochberg correc-
tion was used. For all statistical tests, P  .05 was consid-
ered statistically significant.
RESULTS
Surgical, angiographic, and pathologic findings
Surgical mortality rate was minimal, 8% overall. Carotid
occlusion, with or without recanalization, did not lead to
neurologic deficits in any animal. The arteriotomy itself did
not lead to carotid occlusion, and was followed by minimal
parietal changes, a small local hemorrhagic exudate with
inflammatory cells, at histopathologic analysis (n  3; data
not shown).
The surgical technique was modified to obtain a reli-
able occlusion at 2 days. The use of 0.010-caliber filaments
was followed by occlusion on day 2 in only 53% of arteries,
compared with 84% with 0.015-caliber filaments (P 
Reverse transcriptase–polymerase chain reaction primer seq
Gene Tm NT (bp) Forward
Endothelial
markers
vWF 64 1097 5=-GCGCATCCGCGTG
eNOS 64 834 5=-AGCACCCTGGCAG
VCAM-1 60 400 5=-ATGCCTGTGAAGA
VECAD 64 520 5=-TTGCCCAGCCCTA
PECAM 52 452 5=-AGGGGACCAGCTG
Smooth
muscle
cell
markers
SMA 52 240 5=-GAGAAGCCCAGCC
MMPs MMP-2 58 705 5=-CTTGCAGGAGACA
MMP-9 58 380 5=-CCATGAGTCCCTG
MMP-14 58 643 5=-ACATTCTAACGATC
Inhibitors
of MMPs
TIMP-1 58 655 5=-CTTTGCATCTCTG
TIMP-2 58 584 5=-TGCAGCTGCTCCC
TIMP-3 58 392 5=-AACTCCGACATCG
TIMP-4 58 491 5=-TCGGCTCTAGTGA
Growth
factors
VEGF 60 620-548-
488
5=-GGATCCATGAACT
Ang-1 64 580 5=-CAGTGGCTGCAAA
Ang-2 64 666 5=-CACACTGACCTTC
TNF-a 58 450 5=-CAGCCTCTTCTCA
Receptors Tie-1 64 300 5=-ACCCACTACCAGC
Tie-2 52 414 5=-CCTTCCTACCTGC
Reporter -actin 52/
64
595 5=-CATGGATGACGAT
Ang, Angiopoietin; VEGF, vascular endothelial growth factor; PECAM, pla
VCAM, vascular cell adhesion molecule; eNOS, endothelial nitric oxide syn
necrosis factor; MMP, matrix metalloproteinase; Tie, transient ischemic epis.035; n 15 each). Thus 0.015-caliber filaments were usedfor all further experiments. Carotid arteries implanted with
nonradioactive 0.015-caliber coils were occluded in 57%
(n  30) of arteries on day 15, which confirmed that
recanalization occurred in this model. When the coil was
radioactive recanalization was prevented, as shown by oc-
clusion in 100% of 13 arteries (P  .006).
Pathologic findings were degraded by a number of
artifacts caused by the presence of the metallic foreign body
or by the dissection performed to remove the coil before
sectioning. Planimetric measurements were not performed,
but complete occlusions were associated with obvious de-
crease in the caliber of the carotid artery beyond the seg-
ment bearing the coil. Arteries that remained occluded 15
days after implantation of radioactive or nonradioactive
coils showed a carotid lumen filled with neointimal tissue
composed of collagen and myofibroblasts; arteries im-
planted with nonradioactive coils were recanalized by
spaces lined with endothelial-like cells and surrounded by a
similar neointimal tissue (Fig 2).
mRNA expression after occlusion, thrombus
organization, or recanalization
Evolution of mRNA expression with time after coil
occlusion. Coil occlusion was followed by significant dif-
ferences, as compared with control carotid arteries, in levels
of expression of endothelial markers (VE-Cad, eNOS);
matrix metalloproteinase (MMP-9, MMP-14) and tissue
es for selected genes
r Reverse primer
GTGG-3= 5=-GGCAGTTGCAGACCCTCCTTG-3=
AGTCC-3= 5=-GGTAGCGTTGCTGATCC-3=
TCGC-3= 5=-GTGACCGGCTTCCCAACCTC-3=
ACCTAAAG-3= 5=-ACCACCGCCCTCCTCATCGTAAGT-3=
ATTAGG-3= 5=-AGGCCGCTTCTCTTGACCACTT-3=
CG-3= 5=-CTCTTGCTCTGGGCTTCA-3=
TCTGG-3= 5=-TTAAGGTGGTGCAGGTATCTGG-3=
G-3= 5=-AGTATGGATGTTATGATG-3=
CCG-3= 5=-TCACTGCCCATGAATGACCC-3=
CTGG-3= 5=-AAGTAGACAGTGTTCAGGC-3=
TGCAC-3= 5=-TTATGGGTCCTCGATGTCAAG-3=
CCGGGCC-3= 5=-GGAGAGCATGTCGGTCCAGAGACA-3=
GGCC-3= 5=-CCTCGGTACCAGCTGCAGATG-3=
GCT-3= 5=-GAATTCACCGCCTCGGCTTGTC-3=
TGA-3= 5=-TCTGCACAGTCTCGAAATGG-3=
ACT-3= 5=-TGGTGTCTCTCAGTGCCTTG-3=
TGC-3= 5=-TTGACTTTCTCCTGGTATGAGATA-3=
ATGT-3= 5=-ATCGTGTGCTAGCATTGAGG-3=
= 5=-CCACTACACCTTTCTTTACA-3=
CTGCGC-3= 5=-GCTGTCGCCACGCTCGGTCAGGAT-3=
dothelial cell adhesion molecule; VECAD, vascular endothelium cadherin;
vWF, von Willebrand factor; SMA, smooth muscle -actin; TNF, tumor
IMP, tissue inhibitor of matrix metalloproteinases.uenc
prime
GCA
AAG
TGG
GCA
CAC
AGT
AGT
GCA
CCT
GCAT
CGG
TGAT
TACG
TTCT
AACT
CCCA
TTCC
TGG
TA-3
ATCG
telet eninhibitors of MMPs (TIMP-2, TIMP-4); and growth fac-
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nificant differences in the evolution of expression of certain
genes over time (vWf, eNOS, VCAM-1, MMP-2, TIMP-1,
and Ang-2).
The expression levels of some endothelial markers, such
as VE-Cad and eNOS, were decreased at 2 and 6 days.
Others were decreased, but to levels that were not signifi-
cantly different from control levels (vWf, VCAM-1, Tie-1).
Some genes (vWF, VCAM-1) reached control levels by 15
days (Fig 3), wheres others remained low (VE-Cad,
Fig 1. Coil occlusion model and angiographic results. a, Intraop-
erative photograph shows endoluminal implantation of platinum
coil (arrowheads). b, Transmyocardial angiogram of normal ca-
rotid artery is shown for comparison. Transmyocardial angiograms
2 days (c, e) and 15 days (d, f) after surgical implantation of not
radioactive (c, d) or radioactive (e, f) platinum coils show occlu-
sion on day 2 with both types of coils (c, e). Artery remains
occluded at 15 days when coil is radioactive (arrows in f), but
recanalizes when coil is not radioactive (d).eNOS). Smooth muscle cell -actin (SMA) expressionremained unchanged throughout experiments, whereas
TNF- was significantly increased at 2 days (data not
shown).
Expression of MMP-9 and MMP-14 was elevated as
compared with control arteries, whereas MMP-2 expres-
sion was low early on, at 2 days, but increased to reach
control levels by 15 days (P  .015; Fig 4). Expression of
TIMP-2 was decreased at all times, most significantly at 6
days (P  .001). TIMP-1 expression increased over time
(P  .011 between 2 and 15 days), but remained within
control levels. There was no significant modulation of
TIMP-3. There was significant overexpression of TIMP-4,
maximal at 2 days (P  .011; Fig 4).
Ang-1 showed 8-fold to 12-fold increased expression
compared with controls (P .000), whereas Ang-2 expres-
sion was elevated (P  .047) only on day 6 (Fig 5).
mRNA expression after radioactive coil occlu-
sion. There was no significant difference in evolution over
time in mRNA expression of vWF, PECAM-1; VE-Cad;
eNOS; SMA; TNF-; MMP-2 or MMP-14; TIMP-1,
TIMP-2, or TIMP-3; Tie-1 or Tie-2; and Ang-1 or Ang-2
between arteries implanted with 32P or nonradioactive
coils. Statistically significant differences between arteries
implanted with 32P or nonradioactive coils included de-
creased expression of TIMP-4 (P  .011) and increased
Fig 2. Coil occlusion of carotid artery: pathologic findings. Axial
sections of normal carotid artery (a) and of carotid artery 2 days (b)
or 15 days (c, d) after coil occlusion (arrow in b). Artery is
recanalized (asterisks in c) when coil was not radioactive, whereas
lumen was completely filled with conjunctive tissue (d) when coil
was radioactive. c and d, Images are of sections immediately above
coil. (a, b, Hematoxylin-eosin stain; c, d, Movat pentachrome
stain; original magnification 	100 [a] or 	50 [b-d]).expression of MMP-9 (P  .02).
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Recanalization is constant after coil occlusion of canine
arteries and can be inhibited with -radiation.9,10 Arterial
recanalization after coil occlusion is a well-known clinical
phenomenon. It has also been documented in many spe-
cies, including dogs, pigs, rabbits, and now mice.9,10 It is a
cellular process that occurs in delayed fashion,6-10 within
days, and thus should be distinguished from thrombolysis.
Recanalization in a murine carotid artery coil-occlusion
model can also be inhibited by in situ -radiation. The
murine model was more difficult to standardize, and angio-
graphic results were less reliable than in the canine model,
in which occlusion was found in 100% of arteries within
hours of coil occlusion; thrombotic occlusion persisted for
6 to 10 days, but was constantly followed by recanalization
by 15 days when coils were nonradioactive.9,10,12 We con-
centrated our investigation on the first 2 weeks because, if
recanalization was prevented during this early period it
would not occur later, when animals were followed up for 3
months.10
The small size of the murine carotid artery, compared
with the caliber of the metallic coil, could have been an
Fig 3. Gene expression of endothelial markers. Reverse transcrip-
tase–polymerase chain reaction analysis of carotid arteries im-
planted with radioactive coils (white bars) or nonradioactive coils
(black bars). Results at 2, 6, or 15 days are expressed as ratio
relative to expression found in normal carotid arteries (control
arteries [CTL], gray bars). Note decreased expression of most
genes at 2 and 6 days with both types of coils. vWF, von Willebrand
factor; PECAM, platelet endothelial cell adhesion molecule;
VCAM-1, vascular cell adhesion molecule-1; VE-CAD, vascular
endothelium cadherin; eNOS, endothelial nitric oxide synthase.important factor to explain the decreased efficacy of therecanalization phenomena in mice. Less reliable initial oc-
clusion and delayed recanalization rates may introduce
variability in biomolecular analyses, as well as difficulties in
interpretation of results when animals are sacrificed before
recanalization can be documented at angiography or
pathologic study, when it is presumed that causal mecha-
nisms are active (6-10 days).9-12 Another weakness of the
model is the presence of the metallic foreign body, which
limits pathologic and immunohistologic studies. Many
technical details remain to be adjusted to maximize patho-
logic techniques. We have previously shown in larger spe-
cies that recanalization consisted of formation of endothe-
lial cell–lined longitudinal channels crossing the throm-
botic occlusion.9,10 Although we could not prove the en-
dothelial nature of the cells bordering the channels, we
assume recanalization in this murine model is of a similar
nature.
There has been little interest in recanalization until
recently. A vena cava thrombus organization model has
been described in rats and mice. This model enabled assess-
ment of the effects of local administration of vascular en-
dothelial growth factor, and the potential role of circulating
cells, monocytes, or progenitor cells in venous recanaliza-
tion after thrombotic occlusion.6,7,15-17 Increased organi-
zation with administration of monocyte chemotactic pro-
tein-1 and increased neovascularization with interleukin-8
have also been found in the same model.6,17 Biologic
processes involved in venous and arterial recanalization may
differ, however. In the absence of urokinase plasminogen
activator (u-PA), cellular invasion of venous thrombi, and
consequently organization and recanalization are defi-
cient.13
Cellular and molecular mechanisms responsible for
thrombus organization and recanalization remain poorly
defined. Diverse hypotheses have been reviewed by Moldo-
van and Asahara.5 Organization and recanalization involve
invasion of the clot by parietal or circulating mononuclear
or progenitor cells forming channels, endothelialization,
myofibroblastic invasion, deposition of collagen, and con-
traction of the provisional matrix. Thus there may be
cellular and molecular analogies between organization and
neointima formation and between angiogenesis and recan-
alization. One hypothesis proposes a key role for mono-
cytes, which may drill metalloelastase-positive tunnels
within the fibrin clot, an event potentially followed by
seeding of circulating progenitor cells, at least in angiogen-
esis, but also possible in recanalization.5,15,18
The role of progenitor cells has been emphasized in an
experiment in which deficient organization and recanaliza-
tion in uPA-deficient mice was rescued by infusion of
wild-type “progenitor” cells.7 Bone marrow cells make a
varying contribution to neointima formation, depending
on animal models,3,19,20 and various circulating cellular
lineages may be involved in organization or recanaliza-
tion.6,16,18-20 The controversy regarding the role, or even
the identity, of circulating progenitor cells is underlined by
reports that propose they may be derived from monocytes
or bone marrow monocyte lineage cells,21,22 and may be
betw
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cellular participation in construction of the “new ves-
sels.”23
Endothelial denudation before coil implantation could
prevent recanalization.11,12 Thus in the current murine
model we studied mRNA expression of endothelial markers
(vWf, Tie-2), adhesion molecules (VE-Cad, VCAM-1,
PECAM-1), growth factors (Ang-1, Ang-2), and MMPs
previously shown to be essential to endothelial invasion
and in vitro vessel formation in fibrin matrices, such as
MMP-2, MMP-9, and MMP-14.24-27 The initial decreased
expression of endothelial markers and adhesion molecules,
followed by recovery, may be interpreted as a sign of
endothelial damage caused by coil occlusion followed by
regeneration. The stable expression of Tie-2, with no initial
decrease in expression, may be surprising in this context.
Progenitor circulating or bone marrow cells may, however,
express “endothelial markers” both in vitro and in vivo, and
use similar MMPs to invade matrices, at least in vitro.28
Because monocytes and progenitor cells, including -actin
mural precursor cells, may reach the thrombus early on and
can express markers traditionally attributed to endothelial
cells, interpretation of these experiments at the cellular level
should be done with caution.29
MMPs have a central role in degrading extracellular and
basement membranes, a necessary step in angiogenesis,
which could also be important to thrombus organization
and recanalization. The hypothesis of a milieu that favors
cellular migration into the thrombus is supported by the
substantial increase in MMP-9 and MMP-14, but stable or
decreased expression of their inhibitors (TIMP-1, TIMP-2,
TIMP-3). To our surprise, there was no significant differ-
ence between arteries occluded with nonradioactive coils,
Fig 4. Gene expression of matrix metalloproteinases
transcriptase–polymerase chain rection analysis of MM
radioactive coils (white bars) or nonradioactive coils (blac
to expression found in normal carotid arteries (contro
MMP-9 (P  .003) and TIMP-4 (P  .001) expressionwhich tend to recanalize, and those treated with 32P coils,which remained occluded at all times for most MMPs
studied. The differential expression of MMP-9 is unlikely to
explain inhibition of recanalization with radiation, because
the observed difference is difficult to reconcile with known
properties of MMPs and was most significant at 15 days,
perhaps too late to be causal. MMPs have other properties
that we could link to organization and recanalization.
MMP-2 and MMP-9 have a role in smooth muscle cell
migration and contraction of collagen matrices.30 This
property of smooth muscle cells or myofibroblasts, pre-
sumed essential to thrombus organization, may also be
involved in recanalization.
A contrasting finding was the decreased level of
MMP-2 with both types of coils. Downregulation of
MMP-2 expression has been described in hypoxic condi-
tions, which could have been present after coil occlusion, in
both endothelial and bone marrow mesenchymal cells,
which may have angiogenic potential.31,32 Decreased ex-
pression of eNOS, usually elevated with hypoxia, does not
support this hypothesis.33
MMP activities are counteracted by TIMPs, which can
be used to control neointima formation.34,35 TIMP-1 and
TIMP-3 were little affected whether the coil was radioac-
tive or not. Decreased expression of TIMP-2 could con-
ceivably favor cellular invasion and recanalization, and may
be related to increased Ang-1.36 TIMP-4, expressed after
vascular injury and associated with collagen accumulation,
was significantly elevated only in arteries treated with non-
radioactive coils (Fig 4). Because TIMP-4 reduces smooth
muscle cell migration, it is tempting to speculate that
organization by smooth muscles cells was favored over
recanalization by endothelial or progenitor cells in radioac-
tive arteries.37 Because the functions of TIMP-4 remain
Ps) and tissue inhibitors of MMPs (TIMPs). Reverse
d TIMP expression in carotid arteries implanted with
). Results at 2, 6, or 15 days are expressed as ratio relative
ries [CTL], gray bars). Note significant differences in
een radioactive and nonradioactive coils.(MM
P an
k bars
l artepoorly documented, this finding deserves further study.
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such as Ang-1 and Ang-2, and related receptors Tie-1 and
Tie-2, were also studied.38,39 Angiopoietins share sequence
homologies with fibrinogen, and cause “sprouting angio-
genesis” in fibrin matrices in vitro.38 Thus they may have a
role in endothelial invasion of the thrombus and potentially
in recanalization in this model. Angiopoietins are also
involved in recruitment of perivascular cells, and thus could
favor organization.38 There was increased expression of
Tie-2, but decreased expression of Tie-1, after coil occlu-
sion, although these variations were not found significant
(Fig 5). Ang-2 mRNA showed decreased levels on day 2
when coils were radioactive; it was tempting to speculate
that decreased levels could correlate with decreased recan-
alization, but the difference did not reach statistical signif-
icance. Arteries treated with radioactive or nonradioactive
coils showed 10-fold increased expression of Ang-1, a
growth factor that should favor “angiogenic phenomena.”
Ang-1 has also been shown to associate with stabilization of
vessels, which is consistent with organization of throm-
bus.40 We were unable to document vascular endothelial
growth factor mRNA expression with the primers that we
used. A significant difference in expression of genes in-
Fig 5. Gene expression of angiopoietins (Ang) and rec
analysis of Ang-1 and Ang-2, and Tie-1 and Tie-2 expres
bars) or nonradioactive coils (black bars). Results at 2, 6
in normal carotid arteries (control arteries [CTL], gra
occluded with radioactive coil occurred only on day 2 anvolved in angiogenesis between arteries treated with 32P ornonradioactive coils could have supported a conceptual
analogy between angiogenesis and recanalization.
Conversely, the increasing levels of TNF- and stable
expression of SMA are compatible with smooth muscle
cell or myofibroblastic invasion of the thrombus and sup-
port a hypothetical analogy between thrombus organiza-
tion and neointima formation.41,42
The absence of major differences in the evolution over
time of mRNA in most genes studied suggests that inhibi-
tion of recanalization was not caused by radiation-induced
cell death.
The present work did not permit identification of key
molecular events that would offer a satisfactory, compre-
hensive understanding of mechanisms responsible for re-
canalization, in contrast to organization. It is also impor-
tant to emphasize that RT-PCR gives no indication
regarding biologic activity. Western blot analysis was not
performed, because the scant amount of harvested material
would have necessitated pooling of multiple (up to 5)
carotid specimens per analysis. Functional data, with zy-
mography, for example, could confirm the role of MMPs or
TIMPs in recanalization, and in situ hybridization or im-
munohistochemical methods could provide valuable infor-
s (Tie). Reverse transcriptase–polymerase chain reaction
n carotid arteries implanted with radioactive coils (white
5 days are expressed as ratio relative to expression found
s). Decreased Ang-2 expression when carotid artery is
not reach statistical significance.eptor
sion i
, or 1
y bar
d didmation on a possible link between protein expression and
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could be indicated once we identify a plausible mechanism
and if technical difficulties involved with the study of small
specimens that include metallic coils are overcome. This
first exploration did not cover many interesting cellular or
molecular avenues, such as the potential role of platelets,
monocytes, macrophages, tissue factor, serine proteases, or
their respective inhibitors.
We plan to pursue our investigation by testing the rate
of recanalization after nonradioactive coil occlusion in mice
lacking u-PA or MMP-9 or overexpressing MCP-1.7,30,43
We also wish to explore the competence of the recanaliza-
tion phenomenon in models of diabetes or atherosclero-
sis.44 The mouse strain chosen for this exploratory work can
also be used, with the proper diet, as a model of type II
diabetes.45
CONCLUSION
Arterial recanalization can be prevented by in situ -
radiation. mRNA expression of genes involved in angio-
genesis and neointima formation can also be found with
recanalization or organization of thrombus, but key cellular
and molecular events remain to be better defined.
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